Donor funding kick-starts 24 innovative new cancer research projects
29 August 2018
$1.26m in seed funding was awarded in 2018 to help kick-start some of Peter Mac's most innovative new cancer research initiatives.
2018 recipients
Dr Kara Britt
Cancer Researh
Defining how the stromal microenvironment drives tumour immune escape
Dr Rani Chahal
Cancer Surgery
Virtual Surgery School: optimising perioperative patient outcomes (Virtual PRIME Initiative)
Dr Genevieve Dall
Cancer Research
Will the epigenome reveal mammary-specific preventative targets for Breast Cancer?
Dr Jennifer Devlin
Cancer Research
A novel anaolog-sensitive biotin-labelled ATP to investigate protein kinase activity in cancer
Ms Lara Edbrooke
Cancer Nursing & Allied Health
Increasing social support and improving lifestyle behaviours of women with endometrial cancer: a pilot randomised controlled trial.
Dr Sarah Everitt
Radiation Oncology
Revolutionising the treatment of Breast Cancer with an upright positioning solution
Dr Rae Farnsworth
Cancer Research
Harbouring the enemy: Understanding how lymphatic niches regulate metastasis
Dr Nick Hardcastle
Radiation Oncology
Using artificial intelligence (AI) to enhance clinician’s recognition of and inform targeted interventions for cancer cachexia.
Dr Imran House
Cancer Research
Targeting novel regulators of CXCL9/10 to enhance anti-tumour immunity
Dr Jian Kang
Cancer Research
Using nascent proteomics to design novel combination therapies for MYC driven haematological and prostate cancer
Dr Simon Keam
Cancer Research
The missing link: p53 and cancer immunotherapy
Prof Michael MacManus
Radiation Oncology
Imaging of PD-L1 with Position Emission Tomography in animal tumour models and later in human subjects with Cancer: (IMMUNOPET Study)
Dr Donna Milne
Cancer Nursing & Allied Health
A randomised controlled pilot study of i-Move, a personalised, semi supervised exercise intervention to reduce fatigue for patients receiving immunotherapy for advanced melanoma
Dr Camilla Mitchell
Cancer Research
Screening for mediators of resistance to PI3K inhibitors in colorectal cancer
Dr Vignesh Narasimhan
Cancer Research
A novel precision medicine adaptive clinical trial for patients with unresectable colorectal peritoneal metastases
A/Prof Paul Neeson
Cancer Research
Exploring tumour-resident memory T cells in prostate cancer
Dr Jane Oliaro
Cancer Research
Understanding how melanoma cells avoid natural killer cell recognition and killing using genetic screening
Ms Lara Petelin
Cancer Research
Expediting evidence-based personalised cancer risk assessment in familial cancer practice
Dr Brindha Pillay
Chief Medical Officer
Implementing a psychosexual intervention for couples within the first year post-allogeneic haematopoietic stem cell transplantation: a pilot study
Dr Sara Roth
Cancer Research
Finding the right MAIT for Cancer Therapy - Single - Cell RNA-Sequencing of Mucosal-associated invariant T cells in Blood, Cancer and Healthy Tissue
Dr Karen Sheppard
Cancer Research
Elucidating the mechanisms underpinning the positive association of body fat and response to targeted therapy and immunotherapies in melanoma
Dr Alesha Thai
Medical Oncology
Exploring the immune landscape of nasopharyngeal carcinoma
Dr Kasmira Wilson
Cancer Surgery
Personalising Treatment in Metastatic Colorectal Cancer
Dr Adam Yeo
Cancer Research
On the clinical need of validating state-of-the-art anatomy mapping models to adapt organ deformation in radiotherapy
